相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
Olga Nigro et al.
EUROPEAN JOURNAL OF CANCER (2020)
Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center
Imad El Majzoub et al.
ANNALS OF EMERGENCY MEDICINE (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis
Yucai Wang et al.
JAMA ONCOLOGY (2019)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Toxicity profiles of immunotherapy
S. Cousin et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
Shrujal Baxi et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Immune-related adverse events of immune checkpoint inhibitors: a brief review
G. Myers
CURRENT ONCOLOGY (2018)
Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
Peng-Fei Wang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S. Champiat et al.
ANNALS OF ONCOLOGY (2016)
Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system
Carmelo Aguirre et al.
MEDICINA CLINICA (2016)
分享论文
